Beginner's Mind
Beginner's Mind
Jul 7, 2021
#43: Tilmann Buerckstuemmer and Thomas Moser - Gene-Editing - The Next Game-Changing Technology?
Play • 1 hr 48 min

Thomas Moser and Tilmann Buerckstuemmer lead the Austrian Life Science Company Aelian Biotechnology.

Episode Links:
Article to the Episode:
Video to the Episode:
Aelian Biotechnology:
Thomas Moser:
Tilmann Buerckstuemmer:

Podcast Links:
Podcast Website:
Community Partner:
Christian Soschner:
LSG2G Twitter:
LSG2G Linkedin:
Podcast Episodes:
Episodes on YouTube:

For those who want to listen to specific parts of the episode, here are the timestamps:

(00:00) Introduction
(02:23) Introduction Thomas Moser
(05:45) Introduction Tilmann Bürckstümmer
(08:40) Aelian Biotechnology
(10:20) The Science Behind Aelian
(17:50) Life Science Business Model
(27:00) How to Setup Business Relationships in Life Science
(34:35) Gene Editing - Why Did it Create Such a Hype?
(41:00) History of Gene Editing with Insights Into CRISPR/Cas9
(45:30) Vienna - Part of The CRISPR Community
(47:50) IP of CRISPR
(50:00) CRISPR - Real Life Use Cases
(55:05) CRISPR in Cancer Research
(59:20) Are Genetically Altered Human Beings Possible?
(01:04:20) Genetically Enhanced Human Beings - Reality or SciFi?
(01:08:00) Gene Editing and its Role in Agriculture
(01:12:00) SARS-CoV-2 - What Role Did CRISPR Play in Fighting the Pandemic?
(01:12:20) CRISPR Screen for SARS-CoV-2 - Technology of Aelian Biotechnology
(01:15:00) Drug Discovery for SARS-CoV-2 with CRISPR
(01:18:00) Fundraising for Life Science Companies
(01:27:00) Comparison of the Investment Culture in Europe and the United States
(01:31:00) Major Players in the CRISPR Field
(01:32:00) CRISPR - IP Landscape
(01:44:00) Final Question: Advice for First Time Entrepreneurs

Support the show (
More episodes
Clear search
Close search
Google apps
Main menu